Comparison

Chlorphenoxamine European Partner

Item no. HY-B1607-10mM
Manufacturer MedChem Express
CASRN 77-38-3
Amount 10 mM/1 mL
Quantity options 10 mM/1 mL 10 mg 50 mg 5 mg
Category
Type Inhibitors
Specific against other
Purity 99.20
Citations [1]Ashraf A, et al. Novel RP-HPLC-DAD approach for simultaneous determination of chlorphenoxamine hydrochloride and caffeine with their related substances. BMC Chem. 2024;18(1):133. Published 2024 Jul 19.|[2]Ashraf A, et al. Smart green spectrophotometric estimation and content uniformity testing of chlorphenoxamine HCl and caffeine in bulk forms and combined pharmaceutical formulation. Sci Rep. 2025;15(1):9482. Published 2025 Mar 19.|[3]BAZEX A, et al. Trial treatment of urticaria with chlorphenoxamine. Clinique (Paris). 1963 Jul-Aug;58:447-50.|[4]ULDALL PR, et al. Chlorphenoxamine hydrochloride in parkinsonism. A controlled trial. Br Med J. 1961 Jun 10;1(5240):1649-52.|[5]Schafer A, et al. Repurposing potential of 1st generation H1-specific antihistamines as anti-filovirus therapeutics. Antiviral Res. 2018 Sep;157:47-56.
Smiles CN(CCOC(C1=CC=CC=C1)(C2=CC=C(C=C2)Cl)C)C
ECLASS 10.1 32160490
ECLASS 11.0 32160490
UNSPSC 12000000
Alias 77-38-3
Shipping Condition Room temperature
Available
Manufacturer - Type
Reference compound
Manufacturer - Applications
Neuroscience-Neurodegeneration
Manufacturer - Category
Reference compound / Active compounds; API
Manufacturer - Targets
Filovirus; Histamine Receptor; Parasite; SARS-CoV
Manufacturer - HS Code
H302, H315, H319, H335
Shipping Temperature
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Molecular Weight
303.83
Product Description
Chlorphenoxamine, an antihistamine and anticholinergic agent is a GPCR antagonist. Chlorphenoxamine inhibits multiple lethal viral diseases, such as SARS-CoV, MERS-CoV, EBOV and malaria. Chlorphenoxamine shows anti-filovirus activity against both EBOV and Marburg virus (MARV)  with IC50s of 1.1 μM and 6.2 μM, respectively. Chlorphenoxamine is used for allergic conditions, urticaria, viral diseases and Parkinson’s disease[1][2][3][4][5].
Manufacturer - Research Area
Infection; Inflammation/Immunology; Neurological Disease
Solubility
DMSO : ≥ 48 mg/mL
Manufacturer - Pathway
Anti-infection; GPCR/G Protein; Immunology/Inflammation; Neuronal Signaling
Clinical information
Launched
UNSPSC Code
12352005
Precautionary
H302, H315, H319, H335

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 10 mM/1 mL
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?